These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9041481)

  • 1. Population screening for haemochromatosis: a unifying analysis of published intervention trials.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):178-84. PubMed ID: 9041481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):171-7. PubMed ID: 9041480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing manifestations of hereditary haemochromatosis through population based screening.
    Haddow JE; Ledue TB
    J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for haemochromatosis: influence of analytical imprecision, diagnostic limit and prevalence on test validity.
    Wiggers P; Dalhøj J; Hyltoft Petersen P; Blaabjerg O; Hørder M
    Scand J Clin Lab Invest; 1991 Apr; 51(2):143-8. PubMed ID: 2042019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elevated serum ferritin and hemochromatosis in general practice].
    Mouland G; Bratland B; Hornnes MB; Asser HP; Lier J; Reiso H; Rygh E
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):20-2. PubMed ID: 15643457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based study of the clinical expression of the hemochromatosis gene.
    Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
    N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.
    Edwards CQ; Griffen LM; Goldgar D; Drummond C; Skolnick MH; Kushner JP
    N Engl J Med; 1988 May; 318(21):1355-62. PubMed ID: 3367936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database.
    Adams PC; Gregor JC; Kertesz AE; Valberg LS
    Gastroenterology; 1995 Jul; 109(1):177-88. PubMed ID: 7797016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness.
    Adams PC; Kertesz AE; Valberg LS
    Hepatology; 1995 Dec; 22(6):1720-7. PubMed ID: 7489980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
    Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of haemochromatosis amongst asymptomatic Australians.
    Leggett BA; Halliday JW; Brown NN; Bryant S; Powell LW
    Br J Haematol; 1990 Apr; 74(4):525-30. PubMed ID: 2346731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic efficacy of screening tests for hereditary hemochromatosis.
    Borwein S; Ghent CN; Valberg LS
    Can Med Assoc J; 1984 Oct; 131(8):895-901. PubMed ID: 6593112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.
    Thorstensen K; Kvitland MA; Irgens WØ; Hveem K; Asberg A
    Scand J Clin Lab Invest; 2010 Apr; 70(2):92-7. PubMed ID: 20073670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic haemochromatosis. Family studies and results of a pilot prevalence survey.
    Ballot D; Meyer TE; Bothwell TH; Bezwoda WR; Green A; Baynes RD; Joffe M; Jenkins T
    S Afr Med J; 1987 May; 71(10):639-42. PubMed ID: 3576385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
    Yeap BB; Divitini ML; Gunton JE; Olynyk JK; Beilby JP; McQuillan B; Hung J; Knuiman MW
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A screening test for detecting iron overload in population studies.
    Baynes RD; Meyer TE; Bothwell TH; McNamara L
    S Afr Med J; 1988 Aug; 74(4):167-9. PubMed ID: 3406874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.